EU indices on the upside | TA focus on Proximus

,

European stocks report | Halma | Fresenius | Sanofi | Veolia...

Stocks (3)

INDICES
Yesterday, European stocks closed mixed. The Stoxx Europe 600 Index rebounded 0.20%, Germany's DAX 30 rose 0.41% and the U.K.'s FTSE 100 was up 0.43%, while France's CAC 40 declined 0.40%.

EUROPE ADVANCE/DECLINE
55% of STOXX 600 constituents traded higher yesterday.
29% of the shares trade above their 20D MA vs 26% Monday (below the 20D moving average).
51% of the shares trade above their 200D MA vs 51% Monday (below the 20D moving average).

The Euro Stoxx 50 Volatility index eased 1.77pt to 28.11, a new 52w high.

SECTORS vs STOXX 600
3mths relative high: Pers. & House. Goods
3mths relative low: Insurance, Banks

Europe Best 3 sectors
energy, automobiles & parts, technology

Europe worst 3 sectors
insurance, travel & leisure, basic resources


INTEREST RATE
The 10yr Bund yield fell 5bps to -0.53% (below its 20D MA). The 2yr-10yr yield spread fell 1bp to -21bps (above its 20D MA).


ECONOMIC DATA
GE 07:00: Oct GfK Consumer Confidence, exp.: -1.8
FR 08:15: Sep Markit Composite PMI Flash, exp.: 51.6
FR 08:15: Sep Markit Services PMI Flash, exp.: 51.5
FR 08:15: Sep Markit Manufacturing PMI Flash, exp.: 49.8
GE 08:30: Sep Markit Composite PMI Flash, exp.: 54.4
GE 08:30: Sep Markit Services PMI Flash, exp.: 52.5
GE 08:30: Sep Markit Manufacturing PMI Flash, exp.: 52.2
EC 09:00: ECB Non-Monetary Policy Meeting
EC 09:00: Sep Markit Composite PMI Flash, exp.: 51.9
EC 09:00: Sep Markit Services PMI Flash, exp.: 50.5
EC 09:00: Sep Markit Manufacturing PMI Flash, exp.: 51.7
UK 09:30: Sep Markit/CIPS Manufacturing PMI Flash, exp.: 55.2
UK 09:30: Sep Markit/CIPS UK Services PMI Flash, exp.: 58.8
UK 09:30: Sep Markit/CIPS Composite PMI Flash, exp.: 59.1


MORNING TRADING

In Asian trading hours, the U.S. dollar strengthened further, as EUR/USD slid to 1.1680 and GBP/USD slipped to 1.2721. USD/JPY held gains at 105.12. NZD/USD fell further to 0.6620. This morning, the Reserve Bank of New Zealand kept its benchmark rate unchanged at 0.25% as expected. RBNZ said "further monetary stimulus may be needed", citing "a severe and prolonged economic downturn".

Spot gold was little changed at $1,901 an ounce.


#UK - IRELAND#
Halma, a manufacturer of hazard detection and life protection products, posted a trading update for the period from April 1 to date: "At the end of the first quarter we reported that revenue was 13% lower than last year on an organic constant currency basis. Since then, the Group's revenue trends have gradually improved, (...) Order intake was ahead of revenue albeit marginally down on the same period last year. (...) the Board continues to expect Adjusted profit before tax for FY2021 to be 5%-10% below FY2020 and more weighted to the second half than in previous years." Separately, the company announced that Paul Walker has indicated his intention to retire from his role as Chairman by July.

RELX, a provider of information-based analytics and decision tools, announced that Paul Walker, currently Chairman of Halma, will succeed Sir Anthony Habgood as Chairman.


#GERMANY#
Fresenius, a health care group, was upgraded to "overweight" from "equalweight" at Barclays.

Wacker Chemie, a chemical company, was upgraded to "buy" from "hold" at HSBC.


#FRANCE#
Veolia, a resource management company, is ready to engage in discussion with Engie regarding its proposal to acquire Engie's stake in Suez, according to news agency Agence France-Presse.

Sanofi and GlaxoSmithKline, the two pharmaceutical groups, said they have signed agreements with the Canadian government to supply up to 72 million doses of adjuvanted COVID-19 vaccine. Financial terms were not disclosed.

Orpea, a dependency care company, announced that 1H net income declined 36.3% on year to 73 million euros and EBITDA dropped 5.5% to 439 million euros on revenue of 1.90 billion euros, up 3.5%.


#BENELUX#
Proximus, a mobile telecommunications company, was downgraded to "neutral" from "buy" at Citigroup.
From a chartist point of view, the share is capped by a short term declining trend line since June. Furthermore, the 50 DMA is playing a resistance role, while a resistance at 49% maintains the RSI. Above the overlap at 17.5E look for 13.6E and 9.2E in extension.


Source: TradingView, GAIN Capital


#ITALY#
Snam, an energy infrastructure company, was upgraded to "buy" from "sell" at Goldman Sachs.


#DENMARK#
Coloplast, a medical devices manufacturer, was downgraded to "underweight" from "equalweight" at Barclays.

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.